REUTERS
December 18, 2020 at 15:20 JST
Prepared COVID-19 Pfizer-BioNTech vaccine syringes are seen at Edward Hospital in Naperville, Ill., on Dec. 17. (AP Photo)
Drugmaker Pfizer Inc. said on Friday it had applied for approval in Japan of its COVID-19 vaccine, which is already being administered in the United Kingdom and the United States.
The Japanese government has a supply deal with Pfizer for 120 million vaccine doses of the vaccine made by Pfizer and German partner BioNTech.
Pfizer said in a statement it had made the application to Japan’s Health Ministry, along with providing information on tests it has carried out up to now.
Japan’s Chief Cabinet Secretary Katsunobu Kato told a news conference prior to Pfizer’s announcement that the vaccine’s effectiveness and safety would be priorities.
He added that Japan hoped to have all of its residents vaccinated in the first half of next year and that the government would make every effort for proper arrangements to carry this out.
Pfizer, BioNTech to supply 120 mln doses of coronavirus vaccine to Japan
August 1, 2020
How Pfizer vaccine could be cold comfort for some Asian nations
November 11, 2020Japan in deals with AstraZeneca, Novavax for COVID-19 vaccines
August 8, 2020
FACTBOX: When and which COVID-19 vaccines are likely to be available in Asia
November 27, 2020
South Korea reaches deal to buy AstraZeneca’s COVID-19 vaccine candidate--media
December 3, 2020
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
A peek through the music industry’s curtain at the producers who harnessed social media to help their idols go global.
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series about Japanese-Americans and their memories of World War II
